Collaboration aims to leverage Polyrizon’s advanced proprietary intranasal delivery platform to support clinical development of Clearmind’s drug candidate proprietary MEAI Raanana, Israel, Feb. 06, ...
Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety medication. Phase 1 clinical trial of the patent-pending, rapid-onset ...
Your genetics (traits passed from parents to children) and family history can increase your risk of developing depression. The condition is about 40% heritable (meaning there's a 40% chance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results